Innovative Small Molecule Therapeutics to Combat Rhodococcus equi Pneumonia

Grants and Contracts Details

StatusActive
Effective start/end date1/1/26 → 12/31/26

Funding

  • Boehringer Ingelheim Animal Health USA Incorporated: $15,000.00